Accelerate Diagnostics PE Ratio 2010-2024 | AXDXQ

Current and historical p/e ratio for Accelerate Diagnostics (AXDXQ) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Accelerate Diagnostics PE ratio as of July 25, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Accelerate Diagnostics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-24 0.02 0.00
2024-12-31 1.20 $-2.34 0.00
2024-09-30 1.71 $-2.86 0.00
2024-06-30 1.17 $-2.21 0.00
2024-03-31 0.99 $-4.07 0.00
2023-12-31 3.92 $-4.89 0.00
2023-09-30 5.75 $-5.40 0.00
2023-06-30 8.10 $-7.26 0.00
2023-03-31 7.00 $-7.20 0.00
2022-12-31 7.06 $-7.60 0.00
2022-09-30 15.20 $-9.60 0.00
2022-06-30 9.93 $-9.30 0.00
2022-03-31 14.40 $-10.60 0.00
2021-12-31 52.20 $-12.60 0.00
2021-09-30 58.30 $-12.50 0.00
2021-06-30 80.60 $-14.30 0.00
2021-03-31 83.20 $-14.20 0.00
2020-12-31 75.80 $-14.00 0.00
2020-09-30 106.60 $-14.60 0.00
2020-06-30 151.60 $-15.00 0.00
2020-03-31 83.30 $-15.30 0.00
2019-12-31 169.00 $-15.40 0.00
2019-09-30 185.70 $-15.60 0.00
2019-06-30 228.80 $-16.00 0.00
2019-03-31 210.20 $-16.50 0.00
2018-12-31 115.00 $-16.20 0.00
2018-09-30 229.50 $-14.80 0.00
2018-06-30 223.00 $-13.80 0.00
2018-03-31 228.50 $-12.60 0.00
2017-12-31 262.00 $-11.60 0.00
2017-09-30 224.50 $-12.00 0.00
2017-06-30 273.50 $-12.30 0.00
2017-03-31 242.00 $-12.70 0.00
2016-12-31 207.50 $-12.90 0.00
2016-09-30 272.60 $-12.70 0.00
2016-06-30 143.90 $-11.80 0.00
2016-03-31 143.70 $-11.00 0.00
2015-12-31 214.90 $-10.10 0.00
2015-09-30 161.80 $-9.20 0.00
2015-06-30 258.10 $-8.70 0.00
2015-03-31 225.00 $-7.90 0.00
2014-12-31 191.90 $-7.10 0.00
2014-09-30 214.80 $-6.40 0.00
2014-06-30 260.00 $-5.40 0.00
2014-03-31 218.10 $-4.80 0.00
2013-12-31 122.00 $-4.50 0.00
2013-09-30 134.10 $-3.20 0.00
2013-06-30 81.20 $-2.20 0.00
2013-03-31 72.70 $-1.60 0.00
2012-12-31 40.30 $-0.70 0.00
2012-10-31 36.00 $-4.00 0.00
2012-09-30 33.30 $-4.00 0.00
2012-07-31 32.70 $-3.60 0.00
2012-06-30 26.90 $-3.60 0.00
2012-04-30 27.30 $-0.30 0.00
2012-03-31 10.50 $-0.30 0.00
2012-01-31 12.80 0 0.00
2011-10-31 28.70 0 0.00
2011-07-31 38.90 0 0.00
2011-04-30 38.60 0 0.00
2011-01-31 13.00 0 0.00
2010-10-31 11.00 0 0.00
2010-07-31 8.70 0 0.00
2010-04-30 8.30 0 0.00
2010-01-31 6.84 0 0.00
2009-10-31 12.80 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.000B $0.012B
Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $179.321B 21.70
Intuitive Surgical (ISRG) United States $175.155B 72.60
Alcon (ALC) Switzerland $45.329B 30.63
Edwards Lifesciences (EW) United States $44.464B 29.49
IDEXX Laboratories (IDXX) United States $44.230B 50.83
IQVIA Holdings (IQV) United States $34.139B 19.29
DexCom (DXCM) United States $34.011B 52.57
Mettler-Toledo (MTD) United States $26.202B 31.16
STERIS (STE) Ireland $22.355B 24.62
Waters (WAT) United States $17.762B 25.06
SONOVA HOLDING (SONVY) Switzerland $17.545B 0.00
Hologic (HOLX) United States $14.730B 16.00
Sysmex ADR (SSMXY) Japan $10.852B 30.79
Penumbra (PEN) United States $8.914B 69.96
Masimo (MASI) United States $8.750B 32.28
Globus Medical (GMED) United States $7.214B 17.19
Glaukos (GKOS) United States $5.393B 0.00
Teleflex (TFX) United States $5.135B 8.48
Integer Holdings (ITGR) United States $3.737B 18.72
TransMedics (TMDX) United States $3.612B 78.52
PROCEPT BioRobotics (PRCT) United States $3.244B 0.00
LivaNova (LIVN) United Kingdom $2.360B 14.06
Nihon Kohden (NHNKY) Japan $2.146B 24.61
Elekta AB (EKTAY) Sweden $1.975B 17.76
Veracyte (VCYT) United States $1.847B 25.92
Alphatec Holdings (ATEC) United States $1.566B 0.00
Artivion (AORT) United States $1.326B 124.20
OPKO Health (OPK) United States $1.110B 0.00
Tandem Diabetes Care (TNDM) United States $1.028B 0.00
Pulse Biosciences (PLSE) United States $1.000B 0.00
Integra LifeSciences Holdings (IART) United States $0.988B 5.25
SiBone (SIBN) United States $0.740B 0.00
IRadimed (IRMD) United States $0.720B 36.52
Beta Bionics (BBNX) United States $0.626B 0.00
AxoGen (AXGN) United States $0.602B 0.00
OrthoPediatrics (KIDS) United States $0.553B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.549B 8.55
Semler Scientific (SMLR) United States $0.536B 11.54
Pacific Biosciences Of California (PACB) United States $0.462B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.440B 0.00
Mesa Laboratories (MLAB) United States $0.409B 9.51
Delcath Systems (DCTH) United States $0.397B 0.00
AngioDynamics (ANGO) United States $0.370B 0.00
Treace Medical Concepts (TMCI) United States $0.364B 0.00
RxSight (RXST) United States $0.323B 0.00
ClearPoint Neuro (CLPT) United States $0.316B 0.00
NeuroPace (NPCE) United States $0.297B 0.00
Neuronetics (STIM) United States $0.294B 0.00
908 Devices (MASS) United States $0.265B 0.00
Alpha Tau Medical (DRTS) Israel $0.256B 0.00
Tactile Systems Technology (TCMD) United States $0.238B 14.44
CVRx (CVRX) United States $0.214B 0.00
Monogram Orthopaedics (MGRM) United States $0.204B 0.00
Rapid Micro Biosystems (RPID) United States $0.190B 0.00
Sight Sciences (SGHT) United States $0.184B 0.00
Inogen (INGN) United States $0.183B 0.00
Spectral Diagnostics (EDTXF) Canada $0.169B 0.00
LENSAR (LNSR) United States $0.152B 0.00
Accuray (ARAY) United States $0.141B 0.00
Biosig Technologies (BSGM) United States $0.137B 0.00
Lucid Diagnostics (LUCD) United States $0.119B 0.00
Anteris Technologies Global (AVR) Australia $0.118B 0.00
Atossa Genetics (ATOS) United States $0.111B 0.00
Microbot Medical (MBOT) United States $0.100B 0.00
Sensus Healthcare (SRTS) United States $0.093B 56.50
Hyperfine (HYPR) United States $0.090B 0.00
EnVVeno Medical (NVNO) United States $0.088B 0.00
Vicarious Surgical (RBOT) United States $0.078B 0.00
InspireMD (NSPR) United States $0.075B 0.00
Spectral AI (MDAI) United States $0.069B 0.00
QT Imaging Holdings (QTIH) United States $0.054B 0.00
EDAP TMS S.A (EDAP) France $0.053B 0.00
Covalon Technologies (CVALF) Canada $0.053B 21.33
Positron (POSC) United States $0.051B 0.00
WORK Medical Technology Group (WOK) China $0.047B 0.00
Precision Optics (POCI) United States $0.038B 0.00
Envoy Medical (COCH) United States $0.035B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Adagio Medical Holdings (ADGM) United States $0.026B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.018B 0.00
Baird Medical Investment Holdings (BDMD) $0.014B 0.00
Ekso Bionics Holdings (EKSO) United States $0.011B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.007B 0.00
ENDRA Life Sciences (NDRA) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.29